Institute for Social Science Research, The University of Queensland, 80 Meiers Rd, Indooroopilly QLD, Brisbane, 4068, Australia.
ARC Centre of Excellence for Children and Families Over the Life Course, The University of Queensland, Brisbane, Australia.
J Cancer Surviv. 2024 Jun;18(3):960-971. doi: 10.1007/s11764-023-01346-9. Epub 2023 Feb 24.
Using a discrete dataset from the Women's Wellness after Cancer Program (WWACP), we examine the prevalence and predictors of self-reported sleep problems in women previously treated for cancer.
Participants were 351 women (M = 53.2, SD = 8.8) from the WWACP who had completed surgery, chemotherapy and/or radiotherapy for breast, gynaecological or blood cancers within the previous 24 months. Sleep problems were measured using the Pittsburgh Sleep Quality Index (PSQI). Baseline data (i.e. prior to intervention randomisation) were analysed.
Most women (59%) reported clinically significant sleep disturbance (PSQI > 5), 40% reported insufficient sleep duration (< 7 h), 38% self-reported poor sleep quality and 28% reported poor habitual sleep efficiency (sleep efficiency < 75%). Fewer psychological and vasomotor climacteric symptoms, age < 45 years and having a partner were associated with reduced odds (AOR < 1) of sleep problems. Higher levels of pain-related disability, and an intermediate compared to 'high' level of education, were associated with increased odds (AOR > 1) of sleep problems.
These findings confirm previous studies that have found a high prevalence of sleep problems in women previously treated for cancer. A range of sociodemographic, climacteric and pain-related factors were associated with sleep problems in this study.
Targeted interventions to improve sleep quality after cancer treatment should be explored in this population. Predictors identified in this study could inform intervention targeting and development.
利用女性癌症后健康计划（WWACP）中的离散数据集，我们调查了先前接受癌症治疗的女性中自我报告的睡眠问题的患病率和预测因素。
该研究的参与者是来自 WWACP 的 351 名女性（M=53.2，SD=8.8），她们在过去 24 个月内完成了乳腺癌、妇科或血液癌的手术、化疗和/或放疗。使用匹兹堡睡眠质量指数（PSQI）测量睡眠问题。分析了基线数据（即在干预随机分组之前）。
大多数女性（59%）报告存在临床显著的睡眠障碍（PSQI>5），40%报告睡眠时间不足（<7 小时），38%自我报告睡眠质量差，28%报告习惯性睡眠效率差（睡眠效率<75%）。较少的心理和血管舒缩更年期症状、年龄<45 岁和有伴侣与睡眠问题的几率降低（AOR<1）相关。较高水平的与疼痛相关的残疾，以及与“高”相比处于“中等”水平的教育程度，与睡眠问题的几率增加（AOR>1）相关。
这些发现证实了先前的研究，即先前接受癌症治疗的女性中睡眠问题的患病率很高。本研究中的一系列社会人口学、更年期和与疼痛相关的因素与睡眠问题相关。
应该在这一人群中探索针对癌症治疗后改善睡眠质量的针对性干预措施。本研究中确定的预测因素可以为干预目标和开发提供信息。
